TMPRSS2 and infection: Even when virus inoculants were calculated using an alternative virus titering strategy (based on viral ORF1a RT-qPCR instead of Vero E6-TMPRSS2 infection), BA.1 maintained a significant replicative advantage in nasal monolayers relative to WA1 (Supplemental Figure 1G).